MD financial statements and SEC filings

MD annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$1.91B$208.81M$165.39M10-K
2024-12-31$2.01B-$68.71M-$99.07M10-K
2023-12-31$1.99B$7.32M-$60.41M10-K
2022-12-31$1.97B$172.69M$66.33M10-K
2021-12-31$1.91B$202.92M$130.96M10-K
2020-12-31$1.73B$98.13M-$796.49M10-K

MD annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$2.25B$1.38B$865.85M10-Q
2024-12-31$2.15B$1.39B$764.94M10-K
2023-12-31$2.22B$1.37B$849.06M10-K
2022-12-31$2.35B$1.46B$891.63M10-K
2021-12-31$2.72B$1.83B$896.69M10-K
2020-12-31$3.35B$2.60B$747.72M10-K

MD annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31$271.09M-$18.46M-$107.49M10-K
2024-12-31$206.57M-$22.02M-$14.48M10-K
2023-12-31$137.32M-$33.33M-$25.71M10-K
2022-12-31$166.94M-$29.71M-$487.55M10-K
2021-12-31$76.74M-$32.25M-$760.12M10-K
2020-12-31$204.62M-$28.79M-$4.16M10-K